Grifols Deutschland GmbH

Grifols Deutschland was established in 1997. From the German Headquarters in Frankfurt, we manage the Bioscience sales in Germany, and Diagnostic sales in Germany, Austria and Switzerland (DACH) markets.

We offer a comprehensive portfolio of products and services from the Bioscience and Diagnostic divisions. Safety and quality are our top priorities as we deliver on our mission: improving the health and well-being of people around the world.

Colmarer Strasse 22
60528 Frankfurt am Main
Germany

Contact information
Tel: (49) (69) 660593 100
Fax: (49) (69) 660593 110

Mail:
info.germany@grifols.com
drug.safety1de@grifols.com

Contact Us

Thank you for contacting us. We will reply as soon as possible.

ACCEPT

Thank you for your interest in learning more about our company. We care about your questions and concerns and we will reply you as soon as possible. Please complete all required fields as this will enable us to process your request more efficiently. The company identified in this section is the data controller and will process your personal data based on your consent as expressed in this form. You can exercise your rights of access, rectification, erasure and other data protection rights and obtain additional information on how your personal data is processed in the Privacy Policy

Text to Identify
DATA PROTECTION INFORMATION
Data controller The Grifols' group company to which you have submitted the request
Purpose To attend your requests of information and/or suggestions
Legal basis Consent
Recipients Grifols' group companies
Rights To access, rectify or erase, as well as any other rights as specified in the additional information layer
Additional information You may access the additional and detailed information on data protection here.

Transparency

Industry interactions with the medical profession have a profound and positive influence patient treatment and on the value of research. As primary providers of healthcare services, both healthcare professionals and healthcare organizations, offer us unique, independent insights and expert knowledge on patients' behavior and management of diseases. The capacity of gaining access to this expertise, plays a critical role in informing and guiding industry efforts to improve the quality of patient care and treatment options. And this is why, both healthcare professionals and healthcare organizations, should be fairly compensated for their contributions, as well as for the services they provide to the industry.

Industry interactions with healthcare professionals and healthcare organizations, should not only be conducted with integrity, but should also be transparent. And this is why Grifols Group fully supports, and has voluntarily adopted, the practices reflected in the new EFPIA Disclosure Code, and will continue to support any other country codes which promulgate transparency reporting.

To the above extent, Grifols Deutschland, as member of the AKG e.V. (Arzneimittel und Kooperation im Gesundheitswesen e.V.) is fully supportive of a transparent documentation of all collaborations with healthcare professionals and healthcare organizations, and has adopted the transparency guideline contained in the AKG Code of Conduct. Based on this guideline, Grifols Deutschland publishes, within a publicly available list, all its interactions with German-based healthcare professionals and healthcare organizations.

Per instructions from AKG e.V., these interactions have been split into 4 categories: (a) Research and Development;  (b) Donations; (c) Sponsoring of Educational Events; and (d) Honoraria for Services. Interactions within the category "Research and Development" will be published in an aggregate format. In the other categories, interactions will be published in an individual format, in so far as permitted under German legal requirements on personal data protection.

Commitment to patients

Every day at Grifols, patients inspire our mission to advance the discovery and development of innovative protein therapies that extend and enhance lives. We continually strive to develop new and better products and services to improve our patients' health and well being. To further our mission, Grifols Germany actively supports patient organizations, programs and services that promote education, disease awareness, and patient advocacy efforts in order to improve the diagnosis and treatment of disease.